The FDA has approved Amgen and Allergan’s biosimilar of Roche’s Herceptin, just in time for the breast cancer blockbuster’s patent expiry. Herceptin’s main US patent expires this month ...

MG Motor India starts accepting pre-bookings for its premium CBU electric models, Cyberster and M9. Customers can book these models with a refundable token of Rs 51,000 at select dealerships and ...

The 2025 MG 4 EV has got a few changes in dimensions and the overall design MG has taken over the electric vehicle market in China and is now heading towards a global influence with the MG 4 EV.

Ford’s electric pickup didn’t fare as well. F-150 Lightning Sales were down nearly 15% last month with only 2,199 units sold. Through March, Ford has sold 15% fewer Lightning models than it ...

White House Press Secretary Karoline Leavitt The White House on Tuesday discussed the tariffs various nations have imposed on the United States, specifically mentioning India that imposed 150 per ...

Mundipharma has signed a deal with Celltrion to market a biosimilar of Roche’s Herceptin (trastuzumab) in seven European countries. Breast cancer blockbuster Herceptin earned $2.26 billion in ...

MG might have a history of making small sports cars but ‘new’ MG – the one owned by Chinese automotive giant SAIC – is very much focused on affordable, practical electric cars. So, what on ...

Federal regulators have opened an investigation into nearly 1.3 million Ford F-150 trucks from model years 2015 to 2017. The National Highway Traffic Safety Administration said consumers have ...

But ultimately, the market recovered in just four months—the fastest recovery of any market crash over the past 150 years. So, what have we learned from these recent crashes? It’s impossible ...

You look at India, 150 per cent tariff on American alcohol. Do you think that's helping Kentucky bourbon be exported into India? I don't think so. 100 per cent tariff on agricultural products from ...

Ann Marie Rogers won a landmark victory to make the breast cancer drug Herceptin more widely available. Here, she explains what drove her. But others are asking if the treatment really lives up to ...